Strax

Autospela

The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

2 Visningar • 07/18/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela